Top

Breast Cancer Research and Treatment

Published in:

01-03-2002

Alterations in Cellular Retinol Metabolism Contribute to Differential Retinoid Responsiveness in Normal Human Mammary Epithelial Cells Versus Breast Cancer Cells

Authors: Leslie J. Hayden, Michael A. Satre

Published in: Breast Cancer Research and Treatment | Issue 2/2002

Title: Alterations in Cellular Retinol Metabolism Contribute to Differential Retinoid Responsiveness in Normal Human Mammary Epithelial Cells Versus Breast Cancer Cells
Authors: Leslie J. Hayden
Michael A. Satre
Publication date: 01-03-2002
Publisher: Kluwer Academic Publishers
Published in: Breast Cancer Research and Treatment / Issue 2/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1014815112078

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2002

Letter to the Editor

Loss of Co-ordinate Expression of Progesterone Receptors A and B is an Early Event in Breast Carcinogenesis

The Effect of Flutamide and Tamoxifen on Sex Hormone-Induced Mammary Carcinogenesis and Pituitary Adenoma

Synthesis of Chlorin e6-Transferrin and Demonstration of Its Light-Dependent in vitro Breast Cancer Cell Killing Ability

The Organochlorine Pesticide Residues and Antioxidant Enzyme Activities in Human Breast Tumors: Is There Any Association?

Instructions for Authors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer